معرفی
A/Prof David Pook is an Associate Professor and Medical Oncologist at Monash University, affiliated with the School of Clinical Sciences and the Department of Anatomy and Developmental Biology. His work focuses on clinical and translational research in prostate cancer, particularly the development of novel therapies for genitourinary malignancies. He leads the Prostate Cancer Research Program and holds an external position as a Medical Oncologist at Monash Health since 2010.
Education:
- MBBS (Hons), University of Tasmania
- BMedSci, University of Tasmania
- MD (Targeting Therapy in Colon Cancer), University of Melbourne
- FRACP, Royal Australasian College of Physicians (RACP)
Research Interests:
Dr. Pook’s research emphasizes identifying and testing novel therapeutic agents for genitourinary cancers, including prostate cancer. His work spans radiopharmaceuticals (e.g., Lu-PSMA), immunotherapies (e.g., checkpoint inhibitors), and combination therapies. He also explores cardiovascular risks associated with androgen deprivation therapy and long-term outcomes in metastatic hormone-sensitive prostate cancer.
Recent Projects:
- Monash Cancer Donor Program (2025–2026)
- rechARge Trial (Phase 3, BMS-986365 vs. docetaxel in mCRPC)
- Disitamab Vedotin in HER2-expressing urothelial carcinoma
- Xaluritamig for high-risk prostate cancer recurrence
Grants & Funding:
Dr. Pook is a Primary Chief Investigator for over 40 projects, including major studies funded by industry and national health bodies.
Labs/Teams:
He leads the Prostate Cancer Research Program and collaborates with the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).
